SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Medix - (AMEX: MXR) -- Ignore unavailable to you. Want to Upgrade?


To: REH who wrote (198)12/7/2000 12:10:46 PM
From: scott_jiminez  Read Replies (1) | Respond to of 226
 
REH - I'm curious about one passage:

>>>>
As a result of the corporate organizational changes and related concerns expressed by Mr. Pfeil, the Company and Mr. Pfeil have agreed to amend the terms of his employment agreement. The amendment provides both Mr. Pfeil and the Company with flexibility regarding his future relationship with the Company.
<<<<

Obviously, there's 10X more between the lines than the actual words. Do you any idea what 'concerns' Pfiel had? He also appears to be either quitting or in the process of being fired. Is this simply a function of this consolidation or are you aware of some internal conflicts?

I'm a shareholder. You're a shareholder. I raised a flag about the word 'concerns' in an attempt to maintain my objectivity (otherwise we would have another inane claim that this was 'another excellent move by Medix'). What do you interpret as the positives AND negatives to this announcement?

Objectivity is now absolutely critical in evaluating B2B investments. Without acknowledging the downside risks, especially with respect to management changes, investors are doomed to very poor returns.